MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Posterior tibial nerve Stimulation in the management of Urinary Disorders in Parkinson’s Disease Experience of the National Hospital Center of Pikine

F. Niakam M., N. Mundih, M O. Ngoule, A. Ngassaki, SA. Sow, AM. Diop, J. Kahwagi, MD. Dia, C. Kwama, SA. Jouonang, CB. Bangweni, M. Boukoulou, AG. Faye, C. M. Samba, S. Kamali, M. Ndiaye, M. Fall (Dakar, Senegal)

Meeting: 2026 International Congress

Keywords: Neurostimulation, Parkinson’s, Urinary dysfunction pharmacological management of

Category: Parkinson's Disease: Non-Motor Symptoms (non-Cognitive/ non-Psychiatric)

Objective: Evaluate the efficacy of posterior tibial nerve stimulation in the management of LUTS in patients with PD

Compare posterior tibial nerve stimulation to medication

Background: Lower urinary tract symptoms (LUTS) are common during Parkinson’s Disease (PD) and are accompanied by an impact on patients’ quality of life, but their management has not been clearly defined.

Method: We conducted a prospective and comparative study from January to July 2025 at the Neurology Department of Pikine National Hospital. All patients with PD who complained of LUTS were included. They were divided into two groups: one received posterior tibial nerve stimulation (PTNS), and the other received medical treatment. Patients undergoing stimulation received two 30-minute stimulation sessions per week for a total of six weeks. LUTS were assessed using the International Prostate Symptom Scale (IPSS) at 0, 6, and 12 weeks. Statistical analyses were performed using SPSS version 26.0.

Results: A total of 88 patients with MPI were seen, of whom 37 had LUTS, giving a frequency of 42.5%. The most common urinary symptoms were nocturia and pollakiuria, followed by urgency and incontinence. The IPSS score was higher in patients undergoing stimulation. PTNS resulted in a decrease in the IPSS score in all patients at 6 weeks and in 80% of patients at 12 weeks. The quality of life of patients undergoing stimulation improved at 6 and 12 weeks. There was no significant change in IPSS score and quality of life at 6 and 12 weeks between patients undergoing PTNS and those receiving drug treatment.

Conclusion: LUTS are frequent in Parkinson’s disease and negatively impact quality of life. PTNS improves urinary symptoms and quality of life, showing comparable efficacy to drug therapy, and represents a safe, non-invasive treatment option. Further studies are needed to confirm its long-term benefits.

To cite this abstract in AMA style:

F. Niakam M., N. Mundih, M O. Ngoule, A. Ngassaki, SA. Sow, AM. Diop, J. Kahwagi, MD. Dia, C. Kwama, SA. Jouonang, CB. Bangweni, M. Boukoulou, AG. Faye, C. M. Samba, S. Kamali, M. Ndiaye, M. Fall. Posterior tibial nerve Stimulation in the management of Urinary Disorders in Parkinson’s Disease Experience of the National Hospital Center of Pikine [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/posterior-tibial-nerve-stimulation-in-the-management-of-urinary-disorders-in-parkinsons-disease-experience-of-the-national-hospital-center-of-pikine/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/posterior-tibial-nerve-stimulation-in-the-management-of-urinary-disorders-in-parkinsons-disease-experience-of-the-national-hospital-center-of-pikine/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley